CSF2 and bronchopneumonia: With the inhibitory effect of LP on excessive production of GM-CSF, KC, MCP-1 and PGE2 in LPS-induced RAW 264.7 cells, LP may relieve pulmonary inflammatory disease, such as ALI and bronchial pneumonia.